The most limiting factor I feel is the market cap.

The most limiting factor I feel is the market cap. Shareholders of the BP might be asking, couldn’t you have offered less? An old iHub post of mine below, but the biggest ever last time I searched was 18x (including revenue milestones). Once we get the BLA submission and mono pivotal started, maybe we can get the market cap up to a more reasonable level for BP to give some serious offers. Right now I assume they are just going to coast with financing, grabbing enough cash to get them to that possible inflection point in 6-8 weeks, if the FDA cooperates.

Tobria deal 6x premium cash with up to 18x if certain milestones were met. That 18x was largest premium ever, but with this undervalued market cap to our current successful HIV status and now cancer in play, maybe offer a buyout offer here could beat it.

https://www.businessinsider.com/allergan-acqu...ion-2016-9

Allergan could pay up to a 1,800% premium to acquire a tiny pharmaceutical company